Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurostimulation Enhanced Cognitive Restructuring for Transdiagnostic Emotional Dysregulation: A Component Analysis

NCT05712057 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT05712057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05712057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurostimulation Enhanced Cognitive Restructuring for Transdiagnostic Emotional Dysregulation: A Component Analysis
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Recruiting
Start date
May 15, 2023
Completion date
December 1, 2027
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders, borderline personality disorder, eating disorders, emotion dysregulation, emotion regulation, emotional distress, emotional dysfunction, emotional impulsivity, emotional instability, emotional maladjustment, impulse control disorder, mood disorders, obsessive-compulsive disorder, ocd, stress disorder